Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
1. Evaluate the efficacy of adding anacetrapib 100 mg for 52 weeks relative to placebo on plasma concentrations of LDL-C. 2. Evaluate the safety and tolerability of 52 weeks of treatment with anacetrapib 100 mg.
Inclusion criteria
- Heterozygous Familial Hypercholesterolemia